Home › Trial NCT07070349
A Trial of HRS-6213 in Healthy Subjects and Patients With Solid Tumors
- Trial IDNCT07070349
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorJiangsu HengRui Medicine Co., Ltd.
- Enrollment48
- Start date2025-07-10
- ConditionsPatients With Solid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.